Article
The C677T mutation in the methylenetetrahydrofolate reductase gene predisposes to hyperhomocysteinemia in children with familial hypercholesterolemia treated with cholestyramine.
The Journal of pediatrics - 1 Feb 1998
Tonstad S, Refsum H, Ose L, Ueland P M
Abstract excerpt
In children with familial hypercholesterolemia, heterozygosity and homozygosity for the C677T mutation in the methylenetetrahydrofolate reductase gene was associated with low serum folate and increased susceptibility to elevation of plasma total homocysteine during cholestyramine treatment. Because of the independent relationship between elevated plasma total homocysteine and cardiovascular disease, folate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.